2022 NFID Influenza/Pneumococcal Disease News Conference
Leading national infectious disease experts presented final influenza (flu) vaccine coverage data from the 2021-2022 US flu season and discussed the importance of vaccination against flu and pneumococcal disease, particularly among older adults and those with chronic health conditions who are at higher risk for related complications. Results from a new NFID national survey of US adults were also shared on vaccination attitudes and behaviors, including the impacts of the COVID-19 pandemic, at the 2022 National Foundation for Infectious Diseases (NFID) Influenza/Pneumococcal Disease News Conference on Tuesday, October 4, 2022.
Panelists included: Tamika C. Auguste, MD, ACOG Fellow and Chair, Women’s and Infants’ Services, MedStar Washington Hospital Center; William Schaffner, MD, NFID Medical Director; Patricia (Patsy) A. Stinchfield, RN, MS, CPNP, NFID President (Moderator); Jeb S. Teichman, MD, Retired Pediatrician and Healthcare Executive; and Rochelle P. Walensky, MD, MPH, Centers for Disease Control and Prevention (CDC) Director, with additional expert Alicia M. Fry, MD, MPH, Chief, Epidemiology and Prevention Branch, Influenza Division, CDC.
Leading By Example: NFID initiative calling on leaders in healthcare, business, education, and politics to lead by example by making a commitment to flu prevention. Organizations can join the growing list of supporters and participate in activities to show their support of annual flu vaccination.
News Conference Media Contact: Ned Berkowitz, Ned.Berkowitz@evokegroup.com